Rob De Knegt MD, PhD
Gastroenterology, Hepatology, Internal Medicine and General Medicine
Rotterdam, Zuid Holland, Netherlands
Connect with the speaker?
Dr. De Knegt is currently the consultant in the Erasmus MC University Medical Center. He has received MD Degree from the Erasmus University Rotterdam.
Dr. De Knegt has been in practice for 42 years. His research interests are Viral Hepatitis and Abdominal Sonography.
His publications are as follows:
Retention of CD4+CD25+FoxP3+ regulatory T cells in the liver after therapy-induced hepatitis C virus eradication in humans.(Link) Journal of Virology 2011; 85(11):5323-5330.
Cost utility of telaprevir-PR (peginterferon-ribavirin) versus boceprevir-PR and versus PR alone in chronic hepatitis C in The Netherlands(Link) Appl Health Econ Health Policy.
Dr. De Knegt has been in practice for 42 years. His research interests are Viral Hepatitis and Abdominal Sonography.
His publications are as follows:
Retention of CD4+CD25+FoxP3+ regulatory T cells in the liver after therapy-induced hepatitis C virus eradication in humans.(Link) Journal of Virology 2011; 85(11):5323-5330.
Cost utility of telaprevir-PR (peginterferon-ribavirin) versus boceprevir-PR and versus PR alone in chronic hepatitis C in The Netherlands(Link) Appl Health Econ Health Policy.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)
Quick Links
Connect With Us
Awards & Recognitions
- 50 Division Street, Suite 501,
- Somerville, NJ 08876
- support@emedevents.com